7 May 2019:
A study titled “Tick killing in situ before removal to prevent allergic and anaphylactic reactions in humans: a cross-sectional study” has recently been published. It is available open access from the Asia Pacific Allergy journal https://apallergy.org/DOIx.php?id=10.5415/apallergy.2019.9.e15
Results from this published study support the use of ether containing sprays to kill ticks. These sprays are approved by the TGA for use on human skin in Australia. The study results also support the following ASCIA recommendations.
To prevent allergic reactions to ticks do NOT forcibly remove the tick. Disturbing the tick may cause the tick to inject more allergen-containing saliva. The options are to:
- Leave tick in place and seek medical assistance; OR
- Freeze tick (using a product that rapidly freezes and kills the tick) and allow to drop off.
The ASCIA document on tick allergy is available at www.allergy.org.au/patients/insect-allergy-bites-and-stings/tick-allergy
Another recent publication reports on a second tick species that has been associated with mammalian meat allergy in Australia. https://synapse.koreamed.org/DOIx.php?id=10.5415/apallergy.2018.8.e31
6 May 2019:
It is with great sadness that we read about the recent UK inquest into a case of fatal anaphylaxis of a 13 year old school student, Karanbir Cheema, who had multiple food allergies. https://apple.news/AH7nE6Jr3RHGTrMlPZVp7qQ
The Coroner's Court heard that whilst there were other cases of children having severe allergic reactions through skin contact, none of these incidents had been fatal. The inquest was told that Karanbir had eczema and he scratched at his neck after contact with cheese, with blood visible following the incident. Further scratching and degrading of the skin barrier could have led to increased contact with the cow’s milk protein. His adrenaline (epinephrine) autoinjector was 11 months out of date and this was the only adrenaline administered before he went into cardiac arrest.
30 April 2019:
Bayer Australia Ltd (Bayer) has advised ASCIA that Novalac Allergy formula is currently out of stock and ongoing stock shortages will continue over the coming months. Please note that other Novalac products are unsuitable for infants diagnosed with cow’s milk protein allergy (CMPA). Information on alternative formulas for infants with CMPA is on the ASCIA website: www.allergy.org.au/patients/food-allergy/cows-milk-dairy-allergy
Bayer continues to work as a priority with the global manufacturing partner to increase supply of Novalac Allergy and an update on stock availability will be provided in June.
Novalac Allergy Infant Formula Supply Update April 2019
5 April 2019:
ASCIA greatly appreciates the funding that has been provided by the Australian Government to implement National Allergy Strategy projects. This includes funding that was announced by the Health Minister today, Friday 5 April 2019, which will allow the continuation of these important projects.
Further long-term support is required to implement larger scale projects. As part of World Allergy Week (7-13 April 2019), we encourage anyone who is affected by allergy to support the National Allergy Strategy's $20 million election plea. This plea has been made to all major political parties and you can show your support by signing a petition and sharing it with family and friends.
8 March 2019:
Today, ASCIA is proud to have our three past Presidents and the current President Elect, working together at the inaugural National Immunodeficiency Strategy meeting.
Prof Connie Katelaris, Prof Jo Douglass, Dr Melanie Wong and Prof Michaela Lucas have all made substantial contributions to allergy, clinical immunology and ASCIA.
An example of their ongoing and outstanding commitment, is their involvement in the National Immunodeficiency Strategy meeting, a ground breaking initiative hosted by ASCIA.
13 February 2019:
If you missed watching the Catalyst allergy program on ABC TV last night (12 February 2019), you can watch it on ABC iview https://iview.abc.net.au/show/catalyst
Several ASCIA members were involved in the program, including Prof Connie Katelaris, Prof Dianne Campbell, Dr Preeti Joshi, Carolina Valerio, Rebecca Sertori and Prof Janet Davies.
The Catalyst allergy program highlights the high prevalence, wide range and seriousness of allergic conditions. These include food allergy, anaphylaxis, allergic rhinitis, asthma, eczema and cold urticaria (hives).
Skin testing, food allergen challenge testing, the need to seek professional help from a specialist and examples of current research were featured in the program. It was also explained why more research is required.
How can you help support research?
By making a tax deductable donation to AIFA, this will enable AIFA to fund more allergy/immunology research. www.allergyimmunology.org.au/donate
Expressions of interest (EOI) for AIFA 2019 grants for allergy/immunology research ($120,000 in total) are due by the closing date of 15 April 2019. www.allergyimmunology.org.au/grants
12 February 2019:
Do you have hay fever? Is your asthma made worse by allergens in the air?
Local AusPollen Apps provide daily levels of pollen in the air during the grass pollen season.
To help the AusPollen partnership project team evaluate the Apps and how they can improve this service, please complete a short questionnaire. https://survey.qut.edu.au/f/192811/382e/?LQID=1&
Pollen counting will resume next spring. You can access the service on the website www.pollenforecast.com.au/ or via itunes or Google Play Apps, twitter or facebook.
7 January 2019:
As we commence 2019, we take this opportunity to wish you a happy new year and thank you for your support, which has helped ASCIA achieve so much in 2018.
For a summary of ASCIA highlights from 2018 go to www.allergy.org.au/about-ascia/highlights
In 2019 we are looking forward to celebrating ASCIA’s 30th anniversary, at the ASCIA Annual Conference in Perth Western Australia, from 4-6 September 2019.
For preliminary information go to www.ascia2019.com
The ASCIA Annual Conference is one of the following six priorities for ASCIA in 2019:
1. ASCIA Annual Conference
2. ASCIA Education Project
3. National Immunodeficiency Strategy
4. AIFA Research Grant Program
5. National Allergy Strategy
6. ASCIA Communications, Advocacy and Collaborations
To read more about ASCIA priorities, projects and collaborations planned for 2019 go to